Administration of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and diclofenac in the combination attenuates their anti-tumor activities.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F03%3A17033011" target="_blank" >RIV/68081707:_____/03:17033011 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Administration of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and diclofenac in the combination attenuates their anti-tumor activities.

Original language description

Liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE), an immunomodulator, and diclofenac, an inhibitor of prostaglandin production, were shown earlier to have anti-tumour effects. In the experiments described in this communication it was shownthat combined treatment of mice bearing fibrosarcoma tumours with the above two substances attenuated their anti-tumour activities.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

BO - Biophysics

OECD FORD branch

—

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2003

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Neoplasma

ISSN

0028-2685

e-ISSN

—

Volume of the periodical

50

Issue of the periodical within the volume

3

Country of publishing house

SK - SLOVAKIA

Number of pages

9

Pages from-to

176-184

UT code for WoS article

—

EID of the result in the Scopus database

—